X0306
4
2017-11-17
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001216074
LAMATTINA JOHN L
3911 SORRENTO VALLEY BOULEVARD, STE 110
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2017-11-17
4
M
0
4000
10.12
A
24956
D
Common Stock
2017-11-17
4
S
0
4000
139.79
D
20956
D
Non-Qualified Stock Option (right to buy)
10.12
2017-11-17
2017-11-17
4
M
0
4000
0.0
D
2021-06-01
Common Stock
4000
3335
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.75 to $139.79, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and will fully vest on the first anniversary of the grant date.
By: Charles S. Berkman For: John L. LaMattina
2017-11-17